4//SEC Filing
English Edward C 4
Accession 0001415889-23-000282
CIK 0001840233other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:09 PM ET
Size
5.3 KB
Accession
0001415889-23-000282
Insider Transaction Report
Form 4
English Edward C
Principal Accounting Officer
Transactions
- Award
Stock Option (right to buy)
2023-01-01+24,000→ 24,000 totalExercise: $2.69Exp: 2032-12-31→ Common Stock (24,000 underlying)
Footnotes (1)
- [F1]The option award was granted on January 1, 2023 and shall vest on February 1, 2023 with respect to 1/48th of the shares of common stock underlying the stock option and shall continue to vest in equal monthly installments thereafter until January 1, 2027.
Documents
Issuer
Xilio Therapeutics, Inc.
CIK 0001840233
Entity typeother
Related Parties
1- filerCIK 0001302600
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:09 PM ET
- Size
- 5.3 KB